2021
DOI: 10.1002/bab.2255
|View full text |Cite
|
Sign up to set email alerts
|

microRNAs: Small molecules with a large impact on colorectal cancer

Abstract: Colorectal cancer (CRC) accounts for one of the main cancer‐related mortality and morbidity worldwide. The molecular mechanisms of CRC development have been broadly investigated and, over the last decade, it has become evident that aberrant transcription of microRNAs (miRNAs), a class of small, noncoding RNA molecules, has a significant role in the inception and promotion of CRC. In the involved tissues of CRC, the transcription profile of miRNAs is modulated, and their expression templates are related with pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 156 publications
0
7
0
Order By: Relevance
“…However, there is currently not yet a clear recommendation about the clinical use of these tests. It may be possible, as we previously hypothesized [36], that thanks to the features of ease-of-collection and non-invasiveness, these novel screening techniques, by meeting patient preferences, will improve screening uptake [157,158]. Since none of the retrieved studies (up to July 2021) have investigated population preferences for biomarker-based screening tests, further research is needed to validate this hypothesis.…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…However, there is currently not yet a clear recommendation about the clinical use of these tests. It may be possible, as we previously hypothesized [36], that thanks to the features of ease-of-collection and non-invasiveness, these novel screening techniques, by meeting patient preferences, will improve screening uptake [157,158]. Since none of the retrieved studies (up to July 2021) have investigated population preferences for biomarker-based screening tests, further research is needed to validate this hypothesis.…”
Section: Discussionmentioning
confidence: 95%
“…With regards to perceived invasiveness, it should be noted that a number of newer and promising screening technologies that employ biomarkers such as panels of methylated genes (e.g., SEPT9), microRNAs (miRNA) and protein panels, which can be performed on both blood, stool and, in some cases, urine samples, may become available on the market in the near future [36,157,158]. However, there is currently not yet a clear recommendation about the clinical use of these tests.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to protein-coding transcripts, the transcriptome also consists of many noncoding RNA species, including both small and long noncoding RNAs. The functions of these RNAs have been extensively examined and implicated in important biological pathways [25][26][27][28]. The small noncoding RNAs present a unique opportunity to new therapeutic approaches [29].…”
Section: Transcriptomementioning
confidence: 99%
“…MiRNA was a kind of endogenous non-coding RNA, extensively participating in gene post-transcriptional regulation activities. [33] MiRNA could inhibit target gene expression at protein translation level and induce the degradation of target mRNA. [34] MiR-164a and miR-21 were found to be upregulated over 2-fold in the OLP samples.…”
Section: Degs Of Olpmentioning
confidence: 99%